For the latest news and information about the coronavirus pandemic, visit the World Health Organization and Centers for Disease Control and Prevention websites.
An advisory panel to the U.S. Food and Drug Administration voted Thursday to recommend a booster doseFor many Americans, at least six months after the second dose.
The panel voted unanimously yes on a half-dose dose for people age 65 or older, people age 18 or older at risk of severe COVID-19, and people age 18 or older whose occupation puts them at risk of contracting COVID-19. COVID-19. that’s itLast month.
COVID-19 vaccines are highly effective in preventing hospitalization and death. Over the summer, as the delta variant spreads in the United States, the number of cases, hospitalizations, and deaths from COVID-19 soared. Those who were not vaccinated were counted– Over 97% as of July.
While the United States is already providingFor some people, only 2.5% of people living in low-income countries have received at least one dose of the vaccine.
A vote by an FDA panel is not binding, but the agency will likely accept the recommendation. Food and Drug AdministrationLess than a week after an advisory committee made its recommendation.
The U.S. Food and Drug Administration (FDA) has already granted emergency authorization to obtain a third dose of the Moderna vaccine for some immunocompromised adults.
The committee meets again Friday to discuss a booster dose for the Johnson & Johnson COVID-19 vaccine.